Literature DB >> 2979030

DNA cell cycle studies in uveal melanoma.

D H Char1.   

Abstract

We analyzed the cell cycling status of a group of irradiated and nonirradiated uveal melanomas using BrdUrd techniques. These data demonstrate that melanomas are relatively slow-growing tumors with a few cells actively cycling at a given time. Radiation has a profound effect on the number of cycling cells (P less than .0001). After treatment with either 20 Gy of pre-enucleation photon or 60 Gy or more of helium ion irradiation, virtually no cells are detected in the synthesis phase of the DNA cell cycle. It is unclear whether the absence of cycling cells after 20 Gy of photon irradiation is permanent or represents a transient cell cycle block, since these tumors were studied within 48 hours after irradiation. In contrast, all melanomas treated with helium ion had been irradiated several months prior to enucleation (mean, 2 years). In the latter group of tumors, the length of time between treatment and cell cycle analysis suggests that these cells had lost their reproductive integrity. These data were substantiated by tissue culture studies. Growth of tumor explants was significantly less (P less than .007) in irradiated than in nonirradiated melanomas. The optimum technology used for measurement of cell cycle status remains to be determined. Measurement of BrdUrd uptake using immunofluorescent microscopy on either standard sections or fine-needle biopsies can be performed. In general, flow cytometric analysis yields similar results. It is difficult with the latter technique to be certain that nontumor cells are not artifactitiously counted in the cell cycle studies. The incorporation of BrdUrd cell cycle analysis with fine-needle biopsy may be useful in the clinical management of irradiated melanomas that have questionable growth after treatment. In a few cases studied, results appeared to correlate with tumor growth activity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2979030      PMCID: PMC1298823     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


  103 in total

1.  The culture of uveal melanomas; the Proctor Medal lecture.

Authors:  A B REESE; G EHRLICH
Journal:  Am J Ophthalmol       Date:  1958-11       Impact factor: 5.258

Review 2.  Treatment of choroidal melanomas with 106Ru/106Rh beta-ray applicators.

Authors:  P Lommatzsch
Journal:  Surv Ophthalmol       Date:  1974 Sep-Oct       Impact factor: 6.048

3.  Therapeutic options in uveal melanoma.

Authors:  D H Char
Journal:  Am J Ophthalmol       Date:  1984-12-15       Impact factor: 5.258

4.  Inaccuracy of fine needle aspiration biopsy.

Authors:  G B Krohel; D R Tobin; R M Chavis
Journal:  Ophthalmology       Date:  1985-05       Impact factor: 12.079

5.  Fine needle aspiration biopsy in the diagnosis of intraocular cancer. Cytologic-histologic correlations.

Authors:  J J Augsburger; J A Shields; R Folberg; W Lang; B J O'Hara; J D Claricci
Journal:  Ophthalmology       Date:  1985-01       Impact factor: 12.079

6.  Helium ion charged-particle therapy for choroidal melanoma. Histopathologic findings in a successfully treated case.

Authors:  W S Grizzard; E Torczynski; D H Char
Journal:  Arch Ophthalmol       Date:  1984-04

7.  Cell cycle kinetic measurements in an irradiated rat rhabdomyosarcoma using a monoclonal antibody to bromodeoxyuridine.

Authors:  M Nüsse; S M Afzal; B Carr; K Kavanau
Journal:  Cytometry       Date:  1985-11

8.  Failure of choroidal melanoma to respond to helium ion therapy.

Authors:  D H Char; J B Crawford; J R Castro; K H Woodruff
Journal:  Arch Ophthalmol       Date:  1983-02

9.  Cobalt plaque therapy of posterior uveal melanomas.

Authors:  J A Shields; J J Augsburger; L W Brady; J L Day
Journal:  Ophthalmology       Date:  1982-10       Impact factor: 12.079

10.  Choroidal melanoma. Enucleation or observation? A new approach.

Authors:  W A Manschot; H A van Peperzeel
Journal:  Arch Ophthalmol       Date:  1980-01
View more
  2 in total

Review 1.  Uveal melanoma: cell cycles and survival.

Authors:  I Rennie
Journal:  Br J Ophthalmol       Date:  1995-06       Impact factor: 4.638

Review 2.  Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part II: Oncology, chemotherapy and carcinogenesis.

Authors:  F Dolbeare
Journal:  Histochem J       Date:  1995-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.